MedTrace Logo

Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment

NCT04210128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2023-11-01

No results posted yet for this study

Summary

The purpose of this study is to see if continuous glucose monitoring can identify how often people who have pre-diabetes or medical obesity or well-controlled diabetes experience very high glucose values while receiving chemotherapy for breast cancer or pancreatic.

Conditions

Sponsors & Collaborators

Principal Investigators

  • James Flory, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-20
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04210128 on ClinicalTrials.gov